Recent News

Posted in News

Orbital Micro Systems (OMS) Captures High Resolution Passive Microwave Images of Typhoon Hagibis

Boulder, Colorado, Oct 14, 2019 – (ACN Newswire) – via NEWMEDIAWIRE – Orbital Micro Systems (OMS), a leader in advanced instrumentation for small satellite missions…

Continue Reading... Orbital Micro Systems (OMS) Captures High Resolution Passive Microwave Images of Typhoon Hagibis
Posted in News

PastBook Wins the Deloitte Technology Fast50 2019 for the Media & Entertainment Sector and Makes It to the Podium of the Competition

AMSTERDAM–(BUSINESS WIRE)–At the 20th edition of the Deloitte Technology Fast50 award ceremony, PastBook (https://www.pastbook.com) – the global platform for one click photo products, based in…

Continue Reading... PastBook Wins the Deloitte Technology Fast50 2019 for the Media & Entertainment Sector and Makes It to the Podium of the Competition
Posted in News

Wayfair Introduces New Flagship Brand, Hykkon

Curated home and living collection offers exciting design at an affordable price LONDON–(BUSINESS WIRE)–Wayfair Inc., one of the world’s largest online destinations for the home,…

Continue Reading... Wayfair Introduces New Flagship Brand, Hykkon
Posted in News

Adocia Obtains Additional Financial Resources to Accelerate Its Growth

Establishment of a debt financing plan for a maximum amount of 15 million euros, with IPF Partners First tranche of EUR 7.5 million is subscribed…

Continue Reading... Adocia Obtains Additional Financial Resources to Accelerate Its Growth
Posted in News

Phase III PEMPHIX Study Shows Genentech’s Rituxan (rituximab) Superior to Mycophenolate Mofetil in Patients With Pemphigus Vulgaris

— 40% of patients with pemphigus vulgaris (PV) achieved sustained complete remission, without the use of steroids for 16 weeks or more, when treated with…

Continue Reading... Phase III PEMPHIX Study Shows Genentech’s Rituxan (rituximab) Superior to Mycophenolate Mofetil in Patients With Pemphigus Vulgaris
Posted in News

Novigenix and RadioMedix to Develop Neuroendocrine Cancer Precision Diagnostic Test

Test to measure response to radiopharmaceutical therapy LAUSANNE, Switzerland–(BUSINESS WIRE)–Novigenix SA, a leading Immuno-Transcriptomics company that develops and commercializes solutions for early cancer detection and…

Continue Reading... Novigenix and RadioMedix to Develop Neuroendocrine Cancer Precision Diagnostic Test
Posted in News

Canon Medical to Launch New Division in Dubai, UAE

OHTAWARA, Japan–(BUSINESS WIRE)–#MadeForLife–Canon Medical Systems Corporation is pleased to announce the official opening of its Middle East Division in Canon Middle East Dubai, UAE. Preparations…

Continue Reading... Canon Medical to Launch New Division in Dubai, UAE
Posted in News

Liberty Global Announces CHF 500 Million Conditional Rights Purchase Commitment for Sunrise’s Financing of UPC Switzerland Acquisition

DENVER, Colorado–(BUSINESS WIRE)–Liberty Global plc (“Liberty Global”) (NASDAQ: LBTYA, LBTYB and LBTYK) and Sunrise Communications AG (“Sunrise”) today announced an agreement whereby Liberty Global will…

Continue Reading... Liberty Global Announces CHF 500 Million Conditional Rights Purchase Commitment for Sunrise’s Financing of UPC Switzerland Acquisition
Posted in News

Sun Pharma Launches CEQUA for the Treatment of Dry Eye Disease in the U.S.

CEQUA™ (cyclosporine ophthalmic solution) 0.09% for topical ophthalmic use is the first and only approved cyclosporine treatment delivered with NCELL™technology Sun Pharma introduces CEQUA SUPPORT™Specialty…

Continue Reading... Sun Pharma Launches CEQUA for the Treatment of Dry Eye Disease in the U.S.
Posted in News

Sun Pharma Launches CEQUA for the Treatment of Dry Eye Disease in the U.S.

CEQUA™ (cyclosporine ophthalmic solution) 0.09% for topical ophthalmic use is the first and only approved cyclosporine treatment delivered with NCELL™technology Sun Pharma introduces CEQUA SUPPORT™Specialty…

Continue Reading... Sun Pharma Launches CEQUA for the Treatment of Dry Eye Disease in the U.S.